Hims & Hers Health shares rose Monday after the Food and Drug Administration said compounding pharmacies could continue to ...

Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

CNBC's Karen Gilchrist weighs in on Zealand Pharma's "next generation" obesity drug candidate and its search for a global ...

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

New weight loss jabs could be given to unemployed people to help them get back into work, Sir Keir Starmer has said. The ...

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

It comes after Health Secretary Wes Streeting suggested that weight-loss jabs could be given to unemployed people to help ...

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...